[1]沈诗意,武晓泓.糖尿病血管内皮功能损伤机制及无创评估的研究进展[J].国际内分泌代谢杂志,2024,44(01):35-38.[doi:10.3760/cma.j.cn121383-20230522-05040]
　Shen Shiyi,Wu Xiaohong.Research progress on the mechanism and noninvasive assessment of vascular endothelial dysfunction in diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2024,44(01):35-38.[doi:10.3760/cma.j.cn121383-20230522-05040]
点击复制

糖尿病血管内皮功能损伤机制及无创评估的研究进展()
分享到：

《国际内分泌代谢杂志》[ISSN:1673-4157/CN:12-1383/R]

卷:
44
期数:
2024年01期
页码:
35-38
栏目:
综述
出版日期:
2024-01-20

文章信息/Info

Title:
Research progress on the mechanism and noninvasive assessment of vascular endothelial dysfunction in diabetes mellitus
作者:
沈诗意1; 武晓泓2
1浙江中医药大学第二临床医学院,杭州 310053; 2浙江省人民医院内分泌科,杭州 310014
Author(s):
Shen Shiyi1;  Wu Xiaohong2
1Second Clinical Medical College of Zhejiang Chinese Medical University, Hangzhou 310053, China; 2Department of Endocrinology, Zhejiang Provincial People's Hospital, Hangzhou 310014, China
关键词:
糖尿病;  内皮功能损伤;  机制;  评估方式
Keywords:
Diabetes mellitus;  Endothelial dysfunction;  Mechanism;  Assessment method
DOI:
10.3760/cma.j.cn121383-20230522-05040
摘要:
糖尿病(diabetes mellitus)是一种以高血糖为特征的慢性疾病,其患病率在全球范围内不断上升。心血管病变是糖尿病最主要的并发症之一,具有治疗难度大、病情进展快及死亡率高的特征。血管内皮功能受损是诱发糖尿病心血管并发症的始动环节,其持续存在可以作为评估心血管并发症发生风险的一个重要指标。本文综述了糖尿病患者血管内皮功能损伤的机制及无创评估方式研究进展,以期在糖尿病患者中,早期发现并及时干预内皮功能损伤,降低心血管事件的发生风险。
Abstract:
Diabetes mellitus(DM)is a chronic disease characterized by hyperglycemia, the prevalence of which is increasing worldwide. Cardiovascular disease is one of the main complication of DM, which is characterized by high treatment difficulty, rapid progression,and high mortality. Vascular endothelial dysfunction is the initiating link in the development of diabetic cardiovascular complications, and its persistence can be an important indicator in assessing the risk of vascular complications. This article reviews the research progress on the mechanism and noninvasive assessment of vascular endothelial dysfunction in patients with DM, with the aim of early detection and timely intervention of endothelial function impairment to reduce the risk of cardiovascular events in patients with DM.

参考文献/References:

[1] Wautier JL,Wautier MP.Endothelial cell participation in inflammatory reaction[J].Int J Mol Sci,2021,22(12):6341.DOI:10.3390/ijms22126341.
[2] 张城林,何蕾,王力,等.内皮功能障碍的发生机制[J].中国科学:生命科学,2022,52:691-698.DOI:10.1360/SSV-2021-0251.
[3] Daiber A,Chlopicki S.Revisiting pharmacology of oxidative stress and endothelial dysfunction in cardiovascular disease:evidence for redox-based therapies[J].Free Radic Biol Med,2020,157:15-37.DOI:10.1016/j.freeradbiomed.2020.02.026.
[4] Poznyak AV,Grechko AV,Orekhova VA,et al.Oxidative stress and antioxidants in atherosclerosis development and treatment[J].Biology(Basel),2020,9(3):60.DOI:10.3390/biology9030060.
[5] 张雪,匡洪宇.血糖变异性对糖尿病慢性并发症的作用及其优化策略[J].国际内分泌代谢杂志,2020,40(6):408-411.DOI:10.3760/cma.j.cn121383-20200330-03028.
[6] Xu S,Ilyas I,Little PJ,et al.Endothelial dysfunction in atherosclerotic cardiovascular diseases and beyond:from mechanism to pharmacotherapies[J].Pharmacol Rev,2021,73(3):924-967.DOI:10.1124/pharmrev.120.000096.
[7] Wan Y,Liu Z,Wu A,et al.Hyperglycemia promotes endothelial cell senescence through AQR/PLAU signaling axis[J].Int J Mol Sci,2022,23(5):2879.DOI:10.3390/ijms23052879.
[8] Przygodzki T,Luzak B,Kassassir H,et al.Diabetes and hyperglycemia affect platelet GPIIIa expression.effects on adhesion potential of blood platelets from diabetic patients under in vitro flow conditions[J].Int J Mol Sci,2020,21(9):3222.DOI:10.3390/ijms21093222.
[9] Wang E,Wang H,Chakrabarti S.Endothelial-to-mesenchymal transition:an underappreciated mediator of diabetic complications[J].Front Endocrinol(Lausanne),2023,14:1050540.DOI:10.3389/fendo.2023.1050540.
[10] You M,Liu Y,Wang B,et al.Asprosin induces vascular endothelial-to-mesenchymal transition in diabetic lower extremity peripheral artery disease[J].Cardiovasc Diabetol,2022,21(1):25.DOI:10.1186/s12933-022-01457-0.
[11] Zhang H,Ge S,He K,et al.FoxO1 inhibits autophagosome-lysosome fusion leading to endothelial autophagic-apoptosis in diabetes[J].Cardiovasc Res,2019,115(14):2008-2020.DOI:10.1093/cvr/cvz014.
[12] Liu Y,Xiang H,Xiong W,et al.Glucolipotoxicity induces endothelial cell dysfunction by activating autophagy and inhibiting autophagic flow[J].Diab Vasc Dis Res,2022,19(3):14791641221102513.DOI:10.1177/14791641221102513.
[13] Sun J,Lu H,Liang W,et al.Endothelial TFEB(transcription factor EB)improves glucose tolerance via upregulation of IRS(insulin receptor substrate)1 and IRS2[J].Arterioscler Thromb Vasc Biol,2021,41(2):783-795.DOI:10.1161/ATVBAHA.120.315310.
[14] Heiss C,Rodriguez-Mateos A,Bapir M,et al.Flow-mediated dilation reference values for evaluation of endothelial function and cardiovascular health[J].Cardiovasc Res,2023,119(1):283-293.DOI:10.1093/cvr/cvac095.
[15] Alexander Y,Osto E,Schmidt-Trucksäss A,et al.Endothelial function in cardiovascular medicine:a consensus paper of the european society of cardiology working groups on atherosclerosis and vascular biology,aorta and peripheral vascular diseases,coronary pathophysiology and microcirculation,and thrombosis[J].Cardiovasc Res,2021,117(1):29-42.DOI:10.1093/cvr/cvaa085.
[16] Chen S,Shen Y,Liu YH,et al.Impact of glycemic control on the association of endothelial dysfunction and coronary artery disease in patients with type 2 diabetes mellitus[J].Cardiovasc Diabetol,2021,20(1):64.DOI:10.1186/s12933-021-01257-y.
[17] Morimoto H,Kajikawa M,Oda N,et al.Endothelial function assessed by automatic measurement of enclosed zone flow-mediated vasodilation using an oscillometric method is an independent predictor of cardiovascular events[J].J Am Heart Assoc,2016,5(12):e004385.DOI:10.1161/JAHA.116.004385.
[18] Koo BK,Chung WY,Moon MK.Peripheral arterial endothelial dysfunction predicts future cardiovascular events in diabetic patients with albuminuria:a prospective cohort study[J].Cardiovasc Diabetol,2020,19(1):82.DOI:10.1186/s12933-020-01062-z.
[19] Rubinshtein R,Kuvin JT,Soffler M,et al.Assessment of endothelial function by non-invasive peripheral arterial tonometry predicts late cardiovascular adverse events[J].Eur Heart J,2010,31(9):1142-1148.DOI:10.1093/eurheartj/ehq010.
[20] 吕淑芳,赵晓彤,许慕蓉,等.度拉糖肽对2型糖尿病患者外周血内皮祖细胞数量的影响[J].临床心血管病杂志,2022,38(7):572-576.DOI:10.13201/j.issn.1001-1439.2022.07.011.
[21] Fadini GP,Mehta A,Dhindsa DS,et al.Circulating stem cells and cardiovascular outcomes:from basic science to the clinic[J].Eur Heart J,2020,41(44):4271-4282.DOI:10.1093/eurheartj/ehz923.
[22] Rigato M,Fadini GP.Circulating stem/progenitor cells as prognostic biomarkers in macro-and microvascular disease:a narrative review of prospective observational studies[J].Curr Med Chem,2018,25(35):4507-4517.DOI:10.2174/0929867324666170920154020.
[23] Shityakov S,Nagai M,Ergün S,et al.The protective effects of neurotrophins and microRNA in diabetic retinopathy,nephropathy and heart failure via regulating endothelial function[J].Biomolecules,2022,12(8):1113.DOI:10.3390/biom12081113.

相似文献/References:

[1]郑少雄.罗格列酮和心血管风险——近期文献解读[J].国际内分泌代谢杂志,2007,(04):231.
[2]凌厉,朱本章.胰岛素类似物安全性研究进展[J].国际内分泌代谢杂志,2007,(04):234.
[3]李颖,刘东方.餐后1小时血糖升高的意义及干预[J].国际内分泌代谢杂志,2007,(04):235.
[4]崔巍,施秉银.内质网应激介导β细胞生存/死亡的研究进展[J].国际内分泌代谢杂志,2007,(04):256.
[5]杨叶虹,胡仁明.SELDI-TOF-MS技术及其在糖尿病研究中的应用[J].国际内分泌代谢杂志,2007,(04):261.
[6]高妍.针对华人糖尿病特点优化降糖方案[J].国际内分泌代谢杂志,2007,(04):269.
[7]杨志霞,郭莹辉,杨永生,等.胰岛素泵和多次皮下注射治疗糖尿病的比较[J].国际内分泌代谢杂志,2007,(04):273.
[8]周建英,马向华.胃旁路术减肥同时改善糖代谢的机制[J].国际内分泌代谢杂志,2007,(04):285.
[9]李翠柳,朱大龙.破译肠道代谢信息,驱动治疗革新[J].国际内分泌代谢杂志,2014,(06):383.[doi:10.3760/cma.j.issn.1673-4157.2014.06.006]
　Li Cuiliu*,Zhu Dalong..Deciphering metabolic messages from the gut drives therapeutic innovation[J].International Journal of Endocrinology and Metabolism,2014,(01):383.[doi:10.3760/cma.j.issn.1673-4157.2014.06.006]
[10]袁捷 姜云生 杜彦丽 王肃.1型糖尿病对小鼠早孕时期子宫肌层结构和细胞增殖的影响[J].国际内分泌代谢杂志,2015,(01):6.[doi:10.3760/cma.j.issn.1673-4157.2015.01.002]
　Yuan JieJiang YunshengDu YanliWang Su.Effects of type 1 diabetes on the muscularis structure and cell proliferation of uterine in mice during early pregnancy[J].International Journal of Endocrinology and Metabolism,2015,(01):6.[doi:10.3760/cma.j.issn.1673-4157.2015.01.002]

备注/Memo

备注/Memo:
基金项目:国家自然科学基金(81970714); 浙江省自然科学基金联合基金资助项目(LHDMZ23H070001); 浙江省“高层次人才特殊支持计划”科技领军人才项目(2021R52022); 卫生创新人才项目(2021-CXRC07-01)
通信作者:武晓泓,Email:drxhwu@163.com
更新日期/Last Update: 2024-03-20